Results 161 to 170 of about 1,935,200 (187)

A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents. [PDF]

IEEE Open J Eng Med Biol
Pleouras DS, Loukas VS, Karanasiou G, Katsouras C, Semertzioglou A, Moulas AN, Michalis LK, Fotiadis DI.   +7 more
europepmc   +1 more source

Prognostic significance of serum galectin-3 in predicting cardiovascular outcomes after percutaneous coronary intervention with drug-eluting stents. [PDF]

Front Cardiovasc Med
Choi YJ, Seo SM.
europepmc   +1 more source

Comparative Efficacy and Long-Term Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Coronary Artery Disease: A Systematic Review. [PDF]

Cureus
Amjad H, Ullah A, Shakoor M, Tanveer F, Qureshi M, Jahan F, Manzoor H, Mahmoud MH, Masharifa Ahamed F, Halder A, Dilawar R, Anthony N.   +11 more
europepmc   +1 more source

Long-Term (5-Years) Outcomes of Current Drug-Eluting Stents in Percutaneous Coronary Intervention: A Network Meta-Analysis of Randomized Controlled Trials. [PDF]

Catheter Cardiovasc Interv
Goyal A, Saeed H, Hurjkaliani S, Mashkoor Y, Abdullah, Mahalwar G, Kalra A, Reed GW.   +7 more
europepmc   +1 more source

High-intensity statin on 3-year clinical outcomes in elderly acute myocardial infarction patients underwent percutaneous coronary intervention with drug-eluting stents. [PDF]

Sci Rep
Her AY, Choi BG, Park S, Hyun SJ, Choi CU, Rha SW, Kim YH, Jeong MH.   +7 more
europepmc   +1 more source

Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis. [PDF]

BMC Cardiovasc Disord
Abdelaziz A, Elsayed H, Atta K, Desouky M, Gomaa M, Kadhim H, Mechi A, Abdelaziz M, Ezzat M, Mabrouk MA, Ellabban MH, Zawaneh EA, Hafez A, Elnaggar MY, Sena AO, Bahnasy A, Singer E.   +16 more
europepmc   +1 more source

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial. [PDF]

EClinicalMedicine
Han JK, Hwang D, Yang S, Park SH, Kang J, Yang HM, Park KW, Kang HJ, Koo BK, Hur SH, Kim W, Kim SY, Park SH, Han SH, Kim SH, Shin S, Park K, Lee SJ, Kim JW, Lee N, Kim HS.   +20 more
europepmc   +1 more source

Stent Thrombosis With Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis

Lancet, The, 2012
The relative safety of drug-eluting stents and bare-metal stents, especially with respect to stent thrombosis, continues to be debated. In view of the overall low frequency of stent thrombosis, large sample sizes are needed to accurately estimate ...
Giuseppe Biondi-Zoccai, Elvin Kedhi, Tullio Palmerini   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Outcomes Associated With Drug-Eluting and Bare-Metal Stents: A Collaborative Network Meta-Analysis

Lancet, The, 2007
Stephan Reichenbach, Peter Diem
exaly  

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients With Restenosis After Implantation of a Drug-Eluting Stent (ISAR-DESIRE 3): A Randomised, Open-Label Trial

Lancet, The, 2013
Robert A Byrne, Stefanie Schulz-Schüpke, Julinda Mehilli   +2 more
exaly